185 related articles for article (PubMed ID: 23372784)
1. Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies.
Willett BJ; Kraase M; Logan N; McMonagle E; Varela M; Hosie MJ
PLoS One; 2013; 8(1):e54871. PubMed ID: 23372784
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody.
Willett BJ; Kraase M; Logan N; McMonagle EL; Samman A; Hosie MJ
Retrovirology; 2010 Apr; 7():38. PubMed ID: 20420700
[TBL] [Abstract][Full Text] [Related]
3. Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.
Hosie MJ; Willett BJ; Klein D; Dunsford TH; Cannon C; Shimojima M; Neil JC; Jarrett O
J Virol; 2002 Jun; 76(12):6062-72. PubMed ID: 12021339
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
5. Prior virus exposure alters the long-term landscape of viral replication during feline lentiviral infection.
Zheng X; Carver S; Troyer RM; Terwee JA; VandeWoude S
Viruses; 2011 Oct; 3(10):1891-908. PubMed ID: 22069521
[TBL] [Abstract][Full Text] [Related]
6. Feline immunodeficiency virus env gene evolution in experimentally infected cats.
Kraase M; Sloan R; Klein D; Logan N; McMonagle L; Biek R; Willett BJ; Hosie MJ
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):96-106. PubMed ID: 19897254
[TBL] [Abstract][Full Text] [Related]
7. Feline immunodeficiency virus (FIV) neutralization: a review.
Hosie MJ; Pajek D; Samman A; Willett BJ
Viruses; 2011 Oct; 3(10):1870-90. PubMed ID: 22069520
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.
Pistello M; Matteucci D; Cammarota G; Mazzetti P; Giannecchini S; Del Mauro D; Macchi S; Zaccaro L; Bendinelli M
J Virol; 1999 Feb; 73(2):1518-27. PubMed ID: 9882357
[TBL] [Abstract][Full Text] [Related]
9. Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses.
VandeWoude S; Hageman CL; Hoover EA
J Acquir Immune Defic Syndr; 2003 Sep; 34(1):20-31. PubMed ID: 14501789
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.
Hosie MJ; Flynn JN; Rigby MA; Cannon C; Dunsford T; Mackay NA; Argyle D; Willett BJ; Miyazawa T; Onions DE; Jarrett O; Neil JC
J Virol; 1998 Sep; 72(9):7310-9. PubMed ID: 9696827
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
Broche-Pierre S; Richardson J; Moraillon A; Sonigo P
J Gen Virol; 2005 Sep; 86(Pt 9):2495-2506. PubMed ID: 16099908
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.
Hosie MJ; Dunsford T; Klein D; Willett BJ; Cannon C; Osborne R; Macdonald J; Spibey N; Mackay N; Jarrett O; Neil JC
J Virol; 2000 Oct; 74(20):9403-11. PubMed ID: 11000209
[TBL] [Abstract][Full Text] [Related]
13. Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.
Ledesma-Feliciano C; Hagen S; Troyer R; Zheng X; Musselman E; Slavkovic Lukic D; Franke AM; Maeda D; Zielonka J; Münk C; Wei G; VandeWoude S; Löchelt M
Retrovirology; 2018 May; 15(1):38. PubMed ID: 29769087
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A
Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051
[TBL] [Abstract][Full Text] [Related]
15. A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction.
Willett BJ; McMonagle EL; Logan N; Samman A; Hosie MJ
Retrovirology; 2008 Aug; 5():77. PubMed ID: 18721458
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus.
Bęczkowski PM; Logan N; McMonagle E; Litster A; Willett BJ; Hosie MJ
J Gen Virol; 2015 Mar; 96(Pt 3):671-680. PubMed ID: 25395594
[TBL] [Abstract][Full Text] [Related]
17. Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV.
VandeWoude S; Troyer J; Poss M
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):25-32. PubMed ID: 19896218
[TBL] [Abstract][Full Text] [Related]
18. Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection.
Dietrich I; McMonagle EL; Petit SJ; Vijayakrishnan S; Logan N; Chan CN; Towers GJ; Hosie MJ; Willett BJ
J Virol; 2011 Jun; 85(12):5840-52. PubMed ID: 21490095
[TBL] [Abstract][Full Text] [Related]
19. Prior Puma Lentivirus Infection Modifies Early Immune Responses and Attenuates Feline Immunodeficiency Virus Infection in Cats.
Sprague WS; Troyer RM; Zheng X; Wood BA; Macmillian M; Carver S; VandeWoude S
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677149
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection.
Lutz H; Hofmann-Lehmann R; Leutenegger C; Allenspach K; Cuisinier AM; Cronier J; Duquesne V; Aubert A
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):431-3. PubMed ID: 8882327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
